Exosome PAICS promotes radioresistance of non-small cell lung cancer through reducing radition-induced DNA damage and promoting immune escape via STING signaling pathway

Author:

Meng Lu1,Li Peng1,Zhang Anqi1,Huang Litang1,Luo Shilan1,Wu Xiaoting1,Gong Xiaomei1

Affiliation:

1. Tongji University School of Medicine

Abstract

Abstract Background The development of radiotherapy resistance is a process involving complicated mechanisms, in which tumor-derived exosomes play an important role. Methods Colony formation assay, wound healing assay and immunofluorescence assay were adopted to examine the the effects of radioresistant cell-derived exosomes on the radiosensitivity of receptor NSCLC cells. RNA sequencing was performed to identify the functional gene of radioresistant NSCLC cells. A series of in vitro and in vivo experiments, such as the subcutaneous transplantation tumor model and the flow cytometry, were adopted to study the effect of the functional protein transported by exosomes on NSCLC and the mechanisms invloved. Results We found that radioresistant A549 cell-derived exosomes could attenuate the lethal DNA damage and enhance the radio-resistance of co-cultured NSCLC cells. Phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase (PAICS) was significantly up-regulated in A549/X and A549/X-derived exosomes, suggesting that exosome PAICS may be involved in the development of radio-resistance in NSCLC. The killing effects of irradiation in NSCLC cells were partially restored when reducing PAICS of exosome. The STING signalling pathway was influenced by PAICS. Moreover, The irradiation-mediated tumor regression was weakened when giving A549/X cell-derived exosomes intravenously before radiotherapy. The animal experiments also indicated that exosome PAICS could restrain the tumor regression effect of irradiation through inducing immunosuppressive macroenvironment and promote tumor immune escape. Conclusion Our findings indicate that PAICS, a key enzyme in the purine de novo synthesis pathway, could be transported to the receptor NSCLC cells through exosomes, which might be an important way to cause NSCLC radiotherapy resistance.

Publisher

Research Square Platform LLC

Reference40 articles.

1. Cancer Statistics, 2021[J];Siegel RL;CA Cancer J Clin,2021

2. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J];Sung H;CA Cancer J Clin,2021

3. Combining chemotherapy with PD-1 blockade in NSCLC[J];Mathew M;Pharmacol Ther,2018

4. The biology and management of non-small cell lung cancer[J];Herbst RS;Nature,2018

5. Ni J, Bucci J, Malouf D et al. Exosomes Cancer Radioresistance[J] Front Oncol, 2019, 9.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3